Genomic analysis reveals few genetic alterations in pediatric acute myeloid leukemia

Proceedings of the National Academy of Sciences of the United States of America

Volumn 106, Issue 31, 2009, Pages 12944-12949

  Radtke, Ina ^a   Mullighan, Charles G ^a   Ishii, Masami ^a   Su, Xiaoping ^a   Cheng, Jinjun ^a   Ma, Jing ^a   Ganti, Ramapriya ^a   Cai, Zhongling ^a   Goorha, Salil ^a   Pounds, Stanley B ^a   Cao, Xueyuan ^a   Obert, Caroline ^a   Armstrong, Jianling ^a   Zhang, Jinghui ^b   Song, Guangchun ^a   Ribeiro, Raul C ^a   Rubnitz, Jeffrey E ^a   Raimondi, Susana C ^a   Shurtleff, Sheila A ^a   Downing, James R ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Candidate gene resequencing; Copy number alterations; Loss of heterozygosity (LOH); Microarray; Single nucleotide polymorphism (SNP)

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; CHILD; CHILDHOOD CANCER; COHORT ANALYSIS; GENE SEQUENCE; GENETIC ANALYSIS; GENOME; HUMAN; MAJOR CLINICAL STUDY; MUTATIONAL ANALYSIS; OBSERVATION; POINT MUTATION; PRIORITY JOURNAL; RECURRENT DISEASE; SINGLE NUCLEOTIDE POLYMORPHISM; TUMOR GENE; FEMALE; GENE DOSAGE; GENE TRANSLOCATION; GENETICS; HETEROZYGOSITY LOSS; MALE; MUTATION;

CCDC26 PROTEIN, HUMAN; KINESIN; MLLT4 PROTEIN, HUMAN; MYOSIN; ONCOPROTEIN; RUNX1T1 PROTEIN, HUMAN; SIGNAL PEPTIDE; TRANSCRIPTION FACTOR;

CHILD; FEMALE; GENE DOSAGE; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; KINESIN; LEUKEMIA, MYELOID, ACUTE; LOSS OF HETEROZYGOSITY; MALE; MUTATION; MYOSINS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTO-ONCOGENE PROTEINS; TRANSCRIPTION FACTORS; TRANSLOCATION, GENETIC;

EID: 69149083958     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.0903142106     Document Type: Article

References (41)

1. Kelly LM, Gilliland DG (2002) Genetics of myeloid leukemias. Annu Rev Genomics Hum Genet 3:179-198.
2. Reya T, Morrison SJ, Clarke MF,Weissman IL (2001) Stem cells, cancer, and cancer stem cells. Nature 414:105-111.
3. Schimmer AD (2006) Induction of apoptosis in lymphoid and myeloid leukemia. Curr Oncol Rep 8:430-436.
4. Mullighan CG, et al. (2007) Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia. Nature 446:758-764.
5. Mullighan CG, et al. (2008) BCR-ABL1 lymphoblastic leukaemia is characterized by the deletion of Ikaros. Nature 453:110-114.
6. Dunbar AJ, et al. (2008) 250K single nucleotide polymorphism array karyotyping identifies acquired uniparental disomy and homozygous mutations, including novel missense substitutions of c-Cbl, in myeloid malignancies. Cancer Res 68:10349-10357.
7. Gondek LP, et al. (2008) Chromosomal lesions and uniparental disomy detected by SNP arrays in MDS, MDS/MPD, and MDS-derived AML. Blood 111:1534-1542.
8. Raghavan M, et al. (2005) Genome-wide single nucleotide polymorphism analysis reveals frequent partial uniparental disomy due to somatic recombination in acute myeloid leukemias. Cancer Res 65:375-378.
9. Rucker FG, et al. (2006) Disclosure of candidate genes in acute myeloid leukemia with complex karyotypes using microarray-based molecular characterization. J Clin Oncol 24:3887-3894.
10. Ravindranath Y, et al. (2005) Pediatric Oncology Group (POG) studies of acute myeloid leukemia (AML): A review of four consecutive childhood AML trials conducted between 1981 and 2000. Leukemia 19:2101-2116.
11. Ribeiro RC, et al. (2005) Successive clinical trials for childhood acute myeloid leukemia at St Jude Children's Research Hospital, from 1980 to 2000. Leukemia 19:2125-2129.
12. Rubnitz JE, et al. (2007) Prognostic factors and outcome of recurrence in childhood acute myeloid leukemia. Cancer 109:157-163.
13. Bacher U, Haferlach T, Schoch C, Kern W, Schnittger S (2006) Implications of NRAS mutations in AML: A study of 2502 patients. Blood 107:3847-3853.
14. Frohling S, et al. (2004) CEBPA mutations in younger adults with acute myeloid leukemia and normal cytogenetics: Prognostic relevance and analysis of cooperating mutations. J Clin Oncol 22:624-633.
15. Loh ML, et al. (2004) PTPN11 mutations in pediatric patients with acute myeloid leukemia: Results from the Children's Cancer Group. Leukemia 18:1831-1834.
16. Renneville A, et al. (2008) Cooperating gene mutations in acute myeloid leukemia: A review of the literature. Leukemia 22:915-931.
17. Zwaan CM, et al. (2003) FLT3 internal tandem duplication in 234 children with acute myeloid leukemia: Prognostic significance and relation to cellular drug resistance. Blood 102:2387-2394.
18. BeroukhimR, et al. (2007) Assessing the significance of chromosomal aberrations in cancer: Methodology and application to glioma. Proc Natl Acad Sci USA 104:20007-20012.
19. Futreal PA, et al. (2004) A census of human cancer genes. Nat Rev Cancer 4:177-183.
20. Yin W, Rossin A, Clifford JL, Gronemeyer H (2006) Co-resistance to retinoic acid and TRAIL by insertion mutagenesis into RAM. Oncogene 25:3735-3744.
21. Hirano T, et al. (2008) Genes encoded within 8q24 on the amplicon of a large extrachromosomal element are selectively repressed during the terminal differentiation of HL-60 cells. Mutat Res 640:97-106.
22. Guttman M,et al. (2009) Chromatin signature reveals over a thousand highly conserved large non-coding RNAs in mammals. Nature 458:223-227.
23. Simpson MA, et al. (2007) Mutations in FAM20C are associated with lethal osteosclerotic bone dysplasia (Raine syndrome), highlighting a crucial molecule in bone development. Am J Hum Genet 81:906-912.
24. Shan Z, Parker T, Wiest JS (2004) Identifying novel homozygous deletions by microsatellite analysis and characterization of tumor suppressor candidate 1 gene, TUSC1, on chromosome 9p in human lung cancer. Oncogene 23:6612-6620.
25. Huynh KD, Fischle W, Verdin E, Bardwell VJ (2000) BCoR, a novel corepressor involved in BCL-6 repression. Genes Dev 14:1810-1823.
26. Rius M, Hummel-Eisenbeiss J, Keppler D (2008) ATP-dependent transport of leukotrienes B4 and C4 by the multidrug resistance protein ABCC4 (MRP4). J Pharmacol Exp Ther 324:86-94.
27. Taki T, et al. (1996) Fusion of the MLL gene with two different genes, AF-6 and AF-5alpha, by a complex translocation involving chromosomes 5, 6, 8 and 11 in infant leukemia. Oncogene 13:2121-2130.
28. Deng Q, Huang S (2004) PRDM5 is silenced in human cancers and has growth suppressive activities. Oncogene 23:4903-4910.
29. Zhang Y, Rowley JD (2006) Chromatin structural elements and chromosomal translocations in leukemia. DNA Repair (Amst) 5:1282-1297.
30. Gupta M, et al. (2008) Novel regions of acquired uniparental disomy discovered in acute myeloid leukemia. Genes Chromosomes Cancer 47:729-739.
31. Serrano E, et al. (2008) Uniparental disomy may be associated with microsatellite instability in acute myeloid leukemia (AML) with a normal karyotype. Leuk Lymphoma 49:1178-1183.
32. Beroukhim R, et al. (2006) Inferring loss-of-heterozygosity from unpaired tumors using high-density oligonucleotide SNP arrays. PLoS Comput Biol 2:e41.
33. Nanri T, et al. (2005) Mutations in the receptor tyrosine kinase pathway are associated with clinical outcome in patients with acute myeloblastic leukemia harboring t(8;21)(q22;q22). Leukemia 19:1361-1366.
34. Owen C, Barnett M, Fitzgibbon J (2008) Familial myelodysplasia and acute myeloid leukaemia: A review. Br J Haematol 140:123-132.
35. Weir BA, et al. (2007) Characterizing the cancer genome in lung adenocarcinoma. Nature 450:893-898.
36. Jones S, et al. (2008) Core signaling pathways in human pancreatic cancers revealed by global genomic analyses. Science 321:1801-1806.
37. Anonymous (2008) Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature 455:1061-1068.
38. Parsons DW, et al. (2008) An integrated genomic analysis of human glioblastoma multiforme. Science 321:1807-1812.
39. Leary RJ, et al. (2008) Integrated analysis of homozygous deletions, focal amplifications, and sequence alterations in breast and colorectal cancers. Proc Natl Acad Sci USA 105:16224-16229.
40. Sjoblom T, et al. (2006) The consensus coding sequences of human breast and colorectal cancers. Science 314:268-274.
41. Ley TJ, et al. (2008) DNA sequencing of a cytogenetically normal acute myeloid leukaemia genome. Nature 456:66-72.